<DOC>
<DOCNO>EP-0612731</DOCNO> 
<TEXT>
<INVENTION-TITLE>
Novel guinolone and naphthyridone derivatives
</INVENTION-TITLE>
<CLASSIFICATIONS>A61K3147	A61K3147	A61K31495	A61K31495	A61P3100	A61P3112	A61P3118	C07D23300	C07D23354	C07D24900	C07D24904	C07D24908	C07D40100	C07D40110	C07D40112	C07D40114	C07D47100	C07D47104	C07D52100	C07D52100	</CLASSIFICATIONS>
<CLASSIFICATIONS-THIRD>A61K	A61K	A61K	A61K	A61P	A61P	A61P	C07D	C07D	C07D	C07D	C07D	C07D	C07D	C07D	C07D	C07D	C07D	C07D	C07D	</CLASSIFICATIONS-THIRD>
<CLASSIFICATIONS-FOURTH>A61K31	A61K31	A61K31	A61K31	A61P31	A61P31	A61P31	C07D233	C07D233	C07D249	C07D249	C07D249	C07D401	C07D401	C07D401	C07D401	C07D471	C07D471	C07D521	C07D521	</CLASSIFICATIONS-FOURTH>
<ABSTRACT>
The invention relates to novel quinolone- and naphthyridone-carboxylic acid derivatives of the general formula (I) 
<
IMAGE
>
 where the substituents have the meaning indicated in the description, processes for their preparation, and their use as medicaments, in particular as anti-viral agents.
</ABSTRACT>
<APPLICANTS>
<APPLICANT-NAME>
BAYER AG
</APPLICANT-NAME>
<APPLICANT-NAME>
BAYER AG
</APPLICANT-NAME>
</APPLICANTS>
<INVENTORS>
<INVENTOR-NAME>
BARTEL STEPHAN DR
</INVENTOR-NAME>
<INVENTOR-NAME>
KLEEFELD GERD DR
</INVENTOR-NAME>
<INVENTOR-NAME>
NEUMANN RAINER DR
</INVENTOR-NAME>
<INVENTOR-NAME>
PAESSENS ARNOLD DR
</INVENTOR-NAME>
<INVENTOR-NAME>
REEFSCHLAEGER JUERGEN DR
</INVENTOR-NAME>
<INVENTOR-NAME>
SCHULZE THOMAS-J DR
</INVENTOR-NAME>
<INVENTOR-NAME>
STREISSLE GERT DR
</INVENTOR-NAME>
<INVENTOR-NAME>
BARTEL, STEPHAN, DR.
</INVENTOR-NAME>
<INVENTOR-NAME>
KLEEFELD, GERD, DR.
</INVENTOR-NAME>
<INVENTOR-NAME>
NEUMANN, RAINER, DR.
</INVENTOR-NAME>
<INVENTOR-NAME>
PAESSENS, ARNOLD, DR.
</INVENTOR-NAME>
<INVENTOR-NAME>
REEFSCHLAEGER, JUERGEN, DR.
</INVENTOR-NAME>
<INVENTOR-NAME>
SCHULZE, THOMAS-J., DR.
</INVENTOR-NAME>
<INVENTOR-NAME>
STREISSLE, GERT, DR.
</INVENTOR-NAME>
</INVENTORS>
</TEXT>
</DOC>
